Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Editor’s Page

  • You have access
    Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage
    Johannes Czernin
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 1;
  • You have access
    More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging
    Johannes Czernin, Thaiza Adams and Jeremie Calais
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 969-970; DOI: https://doi.org/10.2967/jnumed.121.264374
  • You have access
    The Annual Journal Impact Factor Saga
    Johannes Czernin
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1177; DOI: https://doi.org/10.2967/jnumed.120.262860
  • You have access
    Humana and 18F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others
    Johannes Czernin and Andrei Iagaru
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 1-2;
  • You have access
    The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
    Johannes Czernin
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1087;
  • You have access
    Unacceptable Denials
    Johannes Czernin and Martin Allen-Auerbach
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 939;
  • You have access
    Two Leaders
    Johannes Czernin
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 773;
  • You have access
    Dr. Li Wenliang and the Time of COVID-19
    Johannes Czernin
    Journal of Nuclear Medicine May 1, 2020, 61 (5) 625; DOI: https://doi.org/10.2967/jnumed.120.245712
  • You have access
    Of Sheep and Wolves: Curtailing Coverage for Essential Imaging Tests Based on Flawed Use and Cost Arguments
    Johannes Czernin, Martin Allen-Auerbach and Jeremie Calais
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1657-1658; DOI: https://doi.org/10.2967/jnumed.119.237636
  • You have access
    Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs
    Johannes Czernin
    Journal of Nuclear Medicine August 1, 2019, 60 (8) 1037; DOI: https://doi.org/10.2967/jnumed.119.233627

Pages

  • Next
  • 1
  • 2
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire